- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Mocetinostat Plus Brentuximab Vedotin
Total 187 results
-
TakedaActive, not recruitingHodgkin DiseaseUnited States, Italy, Brazil, Japan
-
UNC Lineberger Comprehensive Cancer CenterSeagen Inc.Active, not recruitingLymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/LymphomaUnited States
-
Centre Antoine LacassagneMillennium: The Takeda Oncology CompanyCompletedSafety | Clinical EfficacyFrance
-
University of VirginiaMerck Sharp & Dohme LLCRecruitingClassical Hodgkin LymphomaUnited States
-
Northwestern UniversitySeagen Inc.TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell... and other conditionsUnited States
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC; Seagen Inc.Recruiting
-
Sun Yat-sen UniversityNot yet recruiting
-
Fondazione Italiana Linfomi ONLUSTerminatedLymphatic DiseasesItaly
-
Masonic Cancer Center, University of MinnesotaTerminatedGerm Cell TumorUnited States
-
Beijing Children's HospitalEnrolling by invitation
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedDisease, HodgkinUnited States, Canada
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; Seagen Inc.Recruiting
-
Seagen Inc.Active, not recruitingPeripheral T-cell LymphomaUnited States, Czechia, Italy, Spain, United Kingdom, France
-
TakedaSeagen Inc.Active, not recruitingHodgkin LymphomaUnited States, France, Italy, Poland, United Kingdom, Belgium, Hong Kong, Taiwan, Spain, South Africa, Turkey, Canada, Denmark, Korea, Republic of, Australia, Russian Federation, Brazil, Hungary, Norway, Czechia, Japan
-
Columbia UniversityCompletedHodgkin Lymphoma | Anaplastic Large Cell LymphomaCanada, United States
-
Lawson Health Research InstituteSeagen Inc.CompletedDiffuse Cutaneous Systemic SclerosisCanada
-
Memorial Sloan Kettering Cancer CenterSeagen Inc.Recruiting
-
Seagen Inc.Bristol-Myers SquibbActive, not recruitingHodgkin LymphomaUnited States, Australia, Czechia, Italy, Spain, Poland
-
University College, LondonUniversity of Miami; Takeda; European Organisation for Research and Treatment... and other collaboratorsRecruitingHodgkin LymphomaUnited Kingdom, New Zealand, Australia, United States, Belgium, Spain
-
Memorial Sloan Kettering Cancer CenterCity of Hope Medical Center; Stanford University; University of Rochester; Seagen...Active, not recruiting
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedNon-Hodgkin Lymphoma | T-Cell Lymphoma | Anaplastic Large-Cell LymphomaUnited States, Korea, Republic of, Spain, United Kingdom, Taiwan, Czechia, Hungary, France, Israel, Germany, Italy, Denmark, Australia, Poland, Romania, Canada
-
Seagen Inc.TerminatedFollicular B-cell Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma RefractoryUnited States, Italy, Spain, United Kingdom, Czechia, Poland, France
-
Yale UniversityWithdrawnHematopoietic/Lymphoid Cancer | Infectious Mononucleosis | PTLD | Lymphoid Tumor | Plasmacytic Hyperplasia PTLD | Florid Follicular Hyperplasia PTLD | Polymorphic PTLD | Monomorphic PTLD | Classical Hodgkin Lymphoma Type PTLDUnited States
-
Seagen Inc.TerminatedLymphoma, Large B-cell, Diffuse | Lymphoma, B-cellUnited States, Spain, Italy, Czechia, Poland
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedLymphoma, Large-Cell, Anaplastic | Lymphoma, NK-cell | Lymphoma, T-cellUnited States, United Kingdom
-
The Lymphoma Academic Research OrganisationCompletedHIV Infection | Stage III Adult Hodgkin Lymphoma | Stage IV Adult Hodgkin Lymphoma | HIV-associated Hodgkin LymphomaFrance
-
Miltenyi Biomedicine GmbHICON plcRecruitingDiffuse Large B-cell LymphomaSpain, Germany, Netherlands, Belgium, France, Czechia, Austria, Lithuania, Sweden, Hungary, Italy, Poland
-
St Stephens Aids TrustGilead SciencesCompleted
-
The Lymphoma Academic Research OrganisationMillennium Pharmaceuticals, Inc.CompletedHodgkin DiseaseFrance, Belgium
-
Chinese PLA General HospitalNot yet recruitingPD-1 Inhibitor Failed Patients With Classical Hodgkin Lymphoma
-
Patrick ReaganSeagen Inc.Active, not recruitingDiffuse Large B-Cell LymphomaUnited States
-
The Lymphoma Academic Research OrganisationCompleted
-
M.D. Anderson Cancer CenterSeagen Inc.Terminated
-
The Lymphoma Academic Research OrganisationMillennium Pharmaceuticals, Inc.CompletedHodgkin LymphomaNetherlands, France, Belgium, Croatia, Denmark
-
Massachusetts General HospitalSeagen Inc.CompletedHodgkin LymphomaUnited States
-
Millennium Pharmaceuticals, Inc.Seagen Inc.CompletedMycosis Fungoides | Cutaneous T-Cell Lymphoma | Primary Cutaneous Anaplastic Large Cell LymphomaUnited States, France, Italy, United Kingdom, Spain, Switzerland, Brazil, Austria, Belgium, Germany, Poland, Australia
-
University of CologneActive, not recruiting
-
Massachusetts General HospitalCompleted
-
Marjolein SpieringMillennium: The Takeda Oncology CompanyUnknownHodgkin Lymphoma | Relapse | RefractoryNetherlands, France, Denmark, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedAcute Myeloid Leukemia | Leukemia | AMLUnited States
-
St. Jude Children's Research HospitalSeagen Inc.Active, not recruitingStage III Childhood Hodgkin Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Stage II Childhood Hodgkin LymphomaUnited States
-
City of Hope Medical CenterWithdrawnSezary Syndrome | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Mycosis Fungoides | Folliculotropic Mycosis Fungoides | CD30-Positive Neoplastic Cells Present | Refractory Primary Cutaneous T-Cell Non-Hodgkin LymphomaUnited States
-
Merck Sharp & Dohme LLCSeagen Inc.; Astellas Pharma Global Development, Inc.Active, not recruitingUrinary Bladder Cancer, Muscle-invasiveCanada, United States, Australia, Belgium, France, Hungary, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, Thailand, Ukraine, Argentina, Colombia, Denmark, Germany, Ireland, Israel, Japan, Malaysia, Philippines, Sing... and more
-
Mitchell CairoCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; H. Lee Moffitt... and other collaboratorsCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMalignant Mesothelioma | CD30-Positive Neoplastic Cells PresentUnited States
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedNeoplasms | Lymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, Hodgkin | CarcinomasUnited States
-
Northwestern UniversitySeagen Inc.; Robert H. Lurie Cancer CenterUnknownStage III Adult Hodgkin Lymphoma | Stage IV Adult Hodgkin Lymphoma | Stage II Adult Hodgkin Lymphoma | Adult Lymphocyte Depletion Hodgkin Lymphoma | Adult Lymphocyte Predominant Hodgkin Lymphoma | Adult Mixed Cellularity Hodgkin Lymphoma | Adult Nodular Sclerosis Hodgkin LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States